Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.17 USD | -9.30% |
|
0.00% | -34.27% |
26/06 | Transcript : Protalix BioTherapeutics, Inc. - Analyst/Investor Day | |
10/05 | Transcript : Protalix BioTherapeutics, Inc., Q1 2024 Earnings Call, May 10, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.27% | 8.58Cr | |
+19.41% | 4.55TCr | |
+38.65% | 3.94TCr | |
-8.62% | 3.85TCr | |
+26.95% | 3.07TCr | |
-13.50% | 2.6TCr | |
+10.74% | 2.59TCr | |
+44.87% | 1.41TCr | |
+34.36% | 1.27TCr | |
-7.14% | 1.13TCr |
- Stock Market
- Equities
- PLX Stock
- News Protalix BioTherapeutics, Inc.
- Earnings Flash (PBDA) PROTALIX BIOTHERAPEUTICS Reports Q3 Revenue $10.3M